Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds Vivasendocrinology-diabetes-and-growth

Paeds Vivas · endocrinology-diabetes-and-growth

Type 1 diabetes: insulin therapy, technology and ambulatory care — branching viva

Branching viva from the principle that insulin is never stopped, through the sick-day child whose insulin was omitted, the pump-treated child with ketones and a normal-looking site, the hybrid closed-loop child with post-breakfast highs, and the adolescent with loss of hypoglycaemia awareness, to the targets, the transition plan, and the equity of technology access.

branching clinical structured oral
On this page & tools

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalRCPSC Pediatrics

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
You are the paediatric registrar running the diabetes ambulatory clinic and taking referrals. You see in succession: a nine-year-old who developed ketoacidosis after her insulin was stopped for a viral illness, a seven-year-old on a pump with abdominal pain and ketones and a normal-looking cannula site, an eleven-year-old with wildly swinging glucose and firm nodules at her injection sites, and a sixteen-year-old who has lost her hypoglycaemia warning symptoms on a tight HbA1c. The examiner releases information in stages and branches the questioning on your answers.

Branch 1 — Opening: the principle that governs everything

Examiner: "A nine-year-old with type 1 diabetes developed ketoacidosis during a viral illness because her parents stopped her insulin. State the single principle that was broken, and explain the rationale." [2]

Expected: Insulin is never stopped during an intercurrent illness. Fever, infection and the stress response raise insulin needs, so the dose is usually increased; withholding insulin is the commonest precipitant of sick-day ketoacidosis. [2]

Branch probes (examiner selects based on the answer): [2]

  • If the candidate states the principle well, outline the sick-day routine the family should have followed: check glucose every 2–4 hours; check blood ketones at every glucose check; hydrate with small frequent carbohydrate-containing fluids; give extra rapid-acting insulin for hyperglycaemia with ketones per the plan; never omit basal insulin. [2]
  • If the candidate hesitates, state the ketone threshold and clinical signs that should have sent them to hospital before she became acidotic: blood ketones above 1.5 mmol/L and rising; vomiting preventing fluid retention; deep or rapid breathing; drowsiness; persistent hyperglycaemia above 15–20 mmol/L. [2]

Branch 2 — The pump child with ketones

Examiner: "Now a seven-year-old on a pump for two years, six hours of abdominal pain, glucose 19 mmol/L, ketones 2.8 mmol/L. The cannula site looks normal, reservoir half full. Why can she be ketotic this fast, and what do you do?" [3]

Expected: A pump carries no long-acting basal depot, only a rapid analogue through the cannula; a blocked or dislodged cannula removes all insulin within hours even when the site looks normal. Immediate management is to give a rapid-acting insulin correction by pen and change the infusion set. [3]

Branch probes: [3]

  • If the candidate simply raises the basal rate, the suspect site still fails to deliver, ketones climb, and ketoacidosis worsens. [3]
  • Escalate to a full DKA pathway if ketones rise despite the correction, vomiting persists, or the pH falls. [2]

Branch 3 — Swinging glucose and firm nodules

Examiner: "An eleven-year-old, correct regimen, reliable carb counting, but glucose swings wildly and she has firm nodules at her injection sites. What is the diagnosis and the management?" [1]

Expected: Lipohypertrophy from poor site rotation causes erratic and unpredictable insulin absorption and is a leading correctable cause of unstable control. The management is to teach systematic site rotation and avoid injecting into the nodules, which restores absorption predictability. [1]

Branch 4 — Loss of hypoglycaemia awareness

Examiner: "A sixteen-year-old, three severe lows in six months, no longer feels the warning symptoms, HbA1c 6.4 percent. What has happened and what is your next step?" [5]

Expected: Recurrent hypoglycaemia has produced impaired awareness, which predicts the next severe event. The correct step is to raise glycaemic targets temporarily to restore awareness before any tightening — not to lower the target further or increase insulin. [5]

Branch 5 — Targets, technology and transition

Examiner: "Close with the headline targets and the trial you would cite to a family considering closed-loop for their young child." [5]

Expected: The targets are an HbA1c below 7 percent (53 mmol/mol) and a time-in-range above 70 percent with time-below-range below 4 percent. For closed-loop in young children, cite the Wadwa trial of hybrid closed-loop control in young children, noting that automated insulin delivery extends to the two-to-six age group with the meal bolus remaining manual. [4]

Closing probe: When she reaches sixteen, a structured transition beginning in the early to mid-teens, with joint clinics, skills checklists and a formal handover summary, prevents her being lost at the adult handover. [1]

References

  1. [1]Cengiz E; Danne T; et al ISPAD Clinical Practice Consensus Guidelines 2024: Insulin and adjunctive treatments in children and adolescents with diabetes. Horm Res Paediatr, 2024.PMID 39884261
  2. [2]Phelan H; Hanas R; et al Sick day management in children and adolescents with diabetes. Pediatr Diabetes, 2022.PMID 36093857
  3. [3]Biester T; Berget C; et al ISPAD Clinical Practice Consensus Guidelines 2024: Diabetes technologies — insulin delivery. Horm Res Paediatr, 2024.PMID 39657603
  4. [4]Wadwa RP; Reed ZW; et al Trial of hybrid closed-loop control in young children with type 1 diabetes. N Engl J Med, 2023.PMID 36920756
  5. [5]de Bock M; Agwu JC; et al ISPAD Clinical Practice Consensus Guidelines 2024: Glycemic targets. Horm Res Paediatr, 2024.PMID 39701064